[go: up one dir, main page]

FR2770779B1 - HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM - Google Patents

HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM

Info

Publication number
FR2770779B1
FR2770779B1 FR9714073A FR9714073A FR2770779B1 FR 2770779 B1 FR2770779 B1 FR 2770779B1 FR 9714073 A FR9714073 A FR 9714073A FR 9714073 A FR9714073 A FR 9714073A FR 2770779 B1 FR2770779 B1 FR 2770779B1
Authority
FR
France
Prior art keywords
hypoosmolar
hirsutism
cellulite
hypotonic
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9714073A
Other languages
French (fr)
Other versions
FR2770779A1 (en
Inventor
Serge Bernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9513197&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2770779(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to FR9714073A priority Critical patent/FR2770779B1/en
Publication of FR2770779A1 publication Critical patent/FR2770779A1/en
Application granted granted Critical
Publication of FR2770779B1 publication Critical patent/FR2770779B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR9714073A 1997-11-10 1997-11-10 HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM Expired - Fee Related FR2770779B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9714073A FR2770779B1 (en) 1997-11-10 1997-11-10 HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714073A FR2770779B1 (en) 1997-11-10 1997-11-10 HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM

Publications (2)

Publication Number Publication Date
FR2770779A1 FR2770779A1 (en) 1999-05-14
FR2770779B1 true FR2770779B1 (en) 2000-07-21

Family

ID=9513197

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9714073A Expired - Fee Related FR2770779B1 (en) 1997-11-10 1997-11-10 HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM

Country Status (1)

Country Link
FR (1) FR2770779B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017157B2 (en) 2002-05-09 2011-09-13 Osiris Therapeutics, Inc. Method of treating a wound with acidified plasma or serum
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795320B1 (en) * 1999-06-23 2005-09-02 Veronique Bernstein INDICATIONS OF HYPOTONIC SOLUTES AND ANY MODE OF ADMINISTRATION IN AESTHETIC MEDICINE AND CANCEROLOGY
WO2002030432A1 (en) * 2000-06-23 2002-04-18 Cambridgemed, Inc Agent for reduction of scar formation by using wound alkalinization
FR2876907B1 (en) 2004-10-27 2007-02-23 Serge Bernstein AQUEOUS SOLUTIONS FOR THE REDUCTION OF GREAT FABRICS
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US10634741B2 (en) 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
US9808539B2 (en) 2013-03-11 2017-11-07 Endomagnetics Ltd. Hypoosmotic solutions for lymph node detection
WO2016193753A2 (en) 2015-06-04 2016-12-08 Endomagnetics Ltd. Marker materials and forms for magnetic marker localization (mml)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371522A (en) * 1979-04-25 1983-02-01 Gilbard Jeffrey P Keratoconjunctivitis sicca therapy

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017157B2 (en) 2002-05-09 2011-09-13 Osiris Therapeutics, Inc. Method of treating a wound with acidified plasma or serum
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9523748B2 (en) 2013-03-13 2016-12-20 Endomagnetics Ltd Magnetic detector

Also Published As

Publication number Publication date
FR2770779A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
PL336889A1 (en) Preparations of activated protein c
NO20004098L (en) Methods and preparations for the treatment of macrophage-mediated disorders
FR2770779B1 (en) HYPOTONIC OR HYPOOSMOLAR PLASMA SOLUTE FOR THE TREATMENT OF CELLULITE, FIBROSIS, AND HIRSUTISM
FI963883A7 (en) Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunction
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
ITMI951538A0 (en) PROCESS AND SYSTEM FOR THE DEHYDRATION OF FORAGE PARTICULARLY FOR THE DEHYDRATION OF ALfalfa
NO302334B1 (en) Therapeutic analgesic containing "Nimesulide", and method of preparation thereof
NO983465D0 (en) Pharmaceuticals Surface Combination Preparations Containing LHRH Analogues and Anti-Strogens for the Treatment of Gynecological Disorders
NO982727D0 (en) PGE-containing lyophilized liposomes for use in the treatment of erectile dysfunction
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
IT8883551A0 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF DNA
NO991621D0 (en) Anticonvulsant derivatives useful in the treatment of neuropathic pain
FI956313L (en) Metamorphic treatment of the alloy and products made from it
ID17647A (en) SUBSTANCE FOR PROPILACTIC AND TREATMENT FOR DISORDERS OF THE VISION FUNCTION
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
IL114712A0 (en) Microparticle preparations for eliminating dissolved substances from the blood
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
EP0966296A4 (en) CONJUGATED PEPTIDES, IMMUNOLOGICAL REAGENT CONTAINING THEM, AND USE OF SUCH PEPTIDES IN THE TREATMENT OF IMMUNOLOGICAL DISORDERS
AU8799398A (en) Physiological combination of active substances to enhance the skin's defenses against noxious agents
FR2702149B1 (en) Application of lamotrigine in the treatment of neuro-AIDS.
IL133398A0 (en) (s) 2-methylamino-2-phenyl - n-butyl 3,4,5 - trimethoxybenzoate and its application to the treatment of chronic pain
EP0653208A3 (en) Substance P antagonists for the treatment and prevention of solar erythema.
ITBZ950045A0 (en) JEWELRY AND PROCEDURE FOR THE CREATION OF THE SAME.
FR2686096B1 (en) REDUCTION OF THE BENZENE CONTENT IN FUEL.
IL122759A (en) METHOD OF DETERMINING THE DEGREE OF AGGREGATION OF THE betaA4 PEPTIDE

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130731